Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: A meta-Analysis

International Journal of Cancer

Volumn 133, Issue 8, 2013, Pages 1765-1775

  He, Jing ^a,b   Shi, Ting Yan ^a,b   Zhu, Mei Ling ^a,b   Wang, Meng Yun ^a,b   Li, Qiao Xin ^a,b   Wei, Qing Yi ^a,c  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

DNA repair; meta Analysis; polymorphism; susceptibility; XPC

Indexed keywords

MESSENGER RNA; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ASIAN; BLADDER CANCER; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG CANCER; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; XPC GENE;

DNA REPAIR; META-ANALYSIS; POLYMORPHISM; SUSCEPTIBILITY; XPC;

CELL TRANSFORMATION, NEOPLASTIC; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84881548108     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28089     Document Type: Review

References (95)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85.
3. Friedberg EC,. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001; 1: 22-33.
4. Wood RD, Mitchell M, Sgouros J, et al. Human DNA repair genes. Science 2001; 291: 1284-9.
5. De Silva IU, McHugh PJ, Clingen PH, et al. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol 2000; 20: 7980-90.
6. Wood RD,. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 1999; 81: 39-44.
7. Goode EL, Ulrich CM, Potter JD,. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 1513-30.
8. Sugasawa K, Ng JM, Masutani C, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 1998; 2: 223-32.
9. Thoma BS, Vasquez KM,. Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol Carcinog 2003; 38: 1-13.
10. Weiss JM, Weiss NS, Ulrich CM, et al. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2524-30.
11. Blankenburg S, Konig IR, Moessner R, et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 2005; 26: 1085-90.
12. Sak SC, Barrett JH, Paul AB, et al. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J Cancer 2005; 92: 2262-5.
13. Hu Z, Wang Y, Wang X, et al. DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int J Cancer 2005; 115: 478-83.
14. Lee GY, Jang JS, Lee SY, et al. XPC polymorphisms and lung cancer risk. Int J Cancer 2005; 115: 807-13.
15. Vogel U, Overvad K, Wallin H, et al. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. Cancer Lett 2005; 222: 67-74.
16. Festa F, Kumar R, Sanyal S, et al. Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutat Res 2005; 574: 105-11.
17. Wu X, Gu J, Grossman HB, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006; 78: 464-79.
18. Kietthubthew S, Sriplung H, Au WW, et al. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 2006; 209: 21-9.
19. Hirata H, Hinoda Y, Matsuyama H, et al. Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem Biophys Res Commun 2006; 342: 1058-62.
20. Garcia-Closas M, Malats N, Real FX, et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 536-42.
21. Huang WY, Berndt SI, Kang D, et al. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 306-11.
22. Li C, Hu Z, Liu Z, et al. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 2526-32.
23. Mechanic LE, Millikan RC, Player J, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 2006; 27: 1377-85.
24. Shen J, Desai M, Agrawal M, et al. Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 1614-9.
25. Ye W, Kumar R, Bacova G, et al. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis 2006; 27: 1835-41.
26. An J, Liu Z, Hu Z, et al. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 2007; 16: 1633-8.
27. Hirata H, Hinoda Y, Tanaka Y, et al. Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer 2007; 43: 231-7.
28. Hansen RD, Sorensen M, Tjonneland A, et al. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat Res 2007; 619: 68-80.
29. Bai Y, Xu L, Yang X, et al. Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: a case-control study. BMC Cancer 2007; 7: 81.
30. Jorgensen TJ, Visvanathan K, Ruczinski I, et al. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat 2007; 101: 65-71.
31. Zhou RM, Wang N, Guo W,. [Correlation of polymorphisms in xeroderma pigmentosum group C to the risk of ovarian carcinoma]. Zhonghua Liu Xing Bing Xue Za Zhi 2008; 29: 91-2.
32. Fontana L, Bosviel R, Delort L, et al. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res 2008; 28: 1853-6.
33. Chang JS, Wrensch MR, Hansen HM, et al. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer 2008; 123: 2095-104.
34. Raaschou-Nielsen O, Sorensen M, Overvad K, et al. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer 2008; 59: 171-9.
35. Yang ZH, Liang WB, Jia J, et al. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma. Acta Oncol 2008; 47: 379-84.
36. Guo W, Zhou RM, Wan LL, et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum groups A and C and risk of esophageal squamous cell carcinoma in a population of high incidence region of North China. J Cancer Res Clin Oncol 2008; 134: 263-70.
37. Dong Z, Guo W, Zhou R, et al. Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China. J Clin Gastroenterol 2008; 42: 910-5.
38. McWilliams RR, Bamlet WR, Cunningham JM, et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008; 68: 4928-35.
39. Shen J, Gammon MD, Terry MB, et al. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk. Eur J Cancer 2008; 44: 710-7.
40. Smith TR, Levine EA, Freimanis RI, et al. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 2008; 29: 2132-8.
41. Abbasi R, Ramroth H, Becher H, et al. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer 2009; 125: 1431-9.
42. Pan J, Lin J, Izzo JG, et al. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis 2009; 30: 785-92.
43. Li LM, Zeng XY, Ji L, et al. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi 2010; 18: 271-5.
44. Agalliu I, Kwon EM, Salinas CA, et al. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control 2010; 21: 289-300.
45. Long XD, Ma Y, Zhou YF, et al. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population. Hepatology 2010; 52: 1301-9.
46. de Verdier PJ, Sanyal S, Bermejo JL, et al. Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients. Mutat Res 2010; 694: 39-44.
47. Gangwar R, Mandhani A, Mittal RD,. XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. J Cancer Res Clin Oncol 2010; 136: 779-86.
48. Engin AB, Karahalil B, Engin A, et al. Oxidative stress, Helicobacter pylori, and OGG1 Ser326Cys, XPC Lys939Gln, and XPD Lys751Gln polymorphisms in a Turkish population with colorectal carcinoma. Genet Test Mol Biomarkers 2010; 14: 559-64.
49. Engin AB, Karahalil B, Engin A, et al. DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastric carcinoma. Mol Biol Rep 2011; 38: 5379-86.
50. Liu D, Wu HZ, Zhang YN, et al. DNA repair genes XPC, XPG polymorphisms: Relation to the risk of colorectal carcinoma and therapeutic outcome with oxaliplatin-based adjuvant chemotherapy. Mol Carcinog 2011; 51Suppl 1: E83-93.
51. Doherty JA, Weiss NS, Fish S, et al. Polymorphisms in nucleotide excision repair genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2011; 20: 1873-82.
52. Goncalves FT, Francisco G, de Souza SP, et al. European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: a case-control study in a high UV index region in Brazil. J Dermatol Sci 2011; 64: 59-66.
53. Wu Y, Jin M, Liu B, et al. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population. Mol Carcinog 2011; 50: 189-98.
54. Jiao X, Ren J, Chen H, et al. Ala499Val (C>T) and Lys939Gln (A>C) polymorphisms of the XPC gene: their correlation with the risk of primary gallbladder adenocarcinoma-A case-control study in China. Carcinogenesis 2011; 32: 496-501.
55. Roberts MR, Shields PG, Ambrosone CB, et al. Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis 2011; 32: 1223-30.
56. Rouissi K, Bahria IB, Bougatef K, et al. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer 2011; 11: 101.
57. Wu YY, Ma XY, Yao KY, et al. [Association of XPC gene polymorphisms with breast cancer risk]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2011; 40: 252-8.
58. Yang X, Liu D, Wu H, et al. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients. Cancer Sci, in press; doi: 10.1111/j.1349-7006.2012.02312.x.
59. Liu Y, Chen Z, Wei Q, et al. Poly (AT) polymorphism in the XPC gene and smoking enhance the risk of prostate cancer in a low-risk Chinese population. Cancer Genet 2012; 205: 205-11.
60. Forsti A, Angelini S, Festa F, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep 2004; 11: 917-22.
61. Mittal RD, Mandal RK,. Genetic variation in nucleotide excision repair pathway genes influence prostate and bladder cancer susceptibility in North Indian population. Indian J Hum Genet 2012; 18: 47-55.
62. Gil J, Ramsey D, Stembalska A, et al. The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol Biol Rep 2012; 39: 527-34.
63. Sakoda LC, Loomis MM, Doherty JA, et al. Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. Int J Mol Epidemiol Genet 2012; 3: 1-17.
64. Shen M, Berndt SI, Rothman N, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 2005; 116: 768-73.
65. Long XD, Ma Y, Huang YZ, et al. Genetic polymorphisms in DNA repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection-related gastric antrum adenocarcinoma in Guangxi population, China. Mol Carcinog 2010; 49: 611-8.
66. Blankenburg S, Konig IR, Moessner R, et al. No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma. Eur J Hum Genet 2005; 13: 253-5.
67. Broberg K, Bjork J, Paulsson K, et al. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005; 26: 1263-71.
68. Sak SC, Barrett JH, Paul AB, et al. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 2537-41.
69. Monroy CM, Cortes AC, Lopez M, et al. Hodgkin lymphoma risk: role of genetic polymorphisms and gene-gene interactions in DNA repair pathways. Mol Carcinog 2011; 50: 825-34.
70. Holm K, Melum E, Franke A, et al. SNPexp-A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics 2010; 11: 600.
71. He J, Qiu LX, Wang MY, et al. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet 2012; 131: 1235-44.
72. International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789-96.
73. Stranger BE, Forrest MS, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007; 315: 848-53.
74. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
75. DerSimonian R, Laird N,. Meta-Analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
76. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-Analysis. Stat Med 2002; 21: 1539-58.
77. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
78. Rouissi K, Ouerhani S, Hamrita B, et al. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia. Pathol Oncol Res 2011; 17: 879-86.
79. Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004; 25: 729-34.
80. Zhou RM, Li Y, Wang N, et al. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. Ai Zheng 2006; 25: 1113-9.
81. Zhu Y, Lai M, Yang H, et al. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer. Carcinogenesis 2007; 28: 698-703.
82. Mandal RK, Gangwar R, Kapoor R, et al. Polymorphisms in base-excision & nucleotide-excision repair genes & prostate cancer risk in north Indian population. Indian J Med Res 2012; 135: 64-71.
83. Hu ZB, Wang YG, Ma HX, et al. [Association of two exonic genetic polymorphisms in the DNA repair gene XPC with risk of lung cancer in Chinese population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22: 415-8.
84. Wen H, Ding Q, Fang ZJ, et al. Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai. Int Urol Nephrol 2009; 41: 855-64.
85. Cai XL, Gao YH, Yu ZW, et al. [A 1:1 matched case-control study on the interaction between HBV, HCV infection and DNA repair gene XPC Ala499Val, Lys939Gln for primary hepatocellular carcinoma]. Zhonghua Liu Xing Bing Xue Za Zhi 2009; 30: 942-5.
86. Hung RJ, Baragatti M, Thomas D, et al. Inherited predisposition of lung cancer: a hierarchical modeling approach to DNA repair and cell cycle control pathways. Cancer Epidemiol Biomarkers Prev 2007; 16: 2736-44.
87. Berndt SI, Platz EA, Fallin MD, et al. Genetic variation in the nucleotide excision repair pathway and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 2263-9.
88. Zhang L, Zhang Z, Yan W,. Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 2005; 359: 150-5.
89. Millikan RC, Hummer A, Begg C, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis 2006; 27: 610-8.
90. Qiu L, Wang Z, Shi X,. Associations between XPC polymorphisms and risk of cancers: a meta-Analysis. Eur J Cancer 2008; 44: 2241-53.
91. Zhang D, Chen C, Fu X, et al. A meta-Analysis of DNA repair gene XPC polymorphisms and cancer risk. J Hum Genet 2008; 53: 18-33.
92. Francisco G, Menezes PR, Eluf-Neto J, et al. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-Analysis. Eur J Hum Genet 2008; 16: 724-34.
93. Khan SG, Muniz-Medina V, Shahlavi T, et al. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res 2002; 30: 3624-31.
94. Shen MR, Jones IM, Mohrenweiser H,. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998; 58: 604-8.
95. Shen H, Sturgis EM, Khan SG, et al. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res 2001; 61: 3321-5.